Hepatoblastoma in a mosaic trisomy 18 child with hemihypertrophy

Naveed Ahmad1, Kate Wheeler1, Helen Stewart2

  • 1Department of Paediatric Oncology, University of Oxford Hospitals, NHS Trust, Oxford, UK.

BMJ Case Reports
|January 23, 2016
PubMed

Insights

This study reports a rare case of hepatoblastoma in a child with mosaic trisomy 18, a condition not previously documented with this specific cancer. The findings suggest that patients with trisomy 18 may tolerate intensive hepatoblastoma treatment well.

Area of Science:

  • Genetics
  • Pediatric Oncology
  • Developmental Biology

Background:

  • Trisomy 18 (Edwards syndrome) is a genetic disorder associated with developmental delays and increased cancer risk.
  • Hepatoblastoma is a rare liver cancer primarily affecting young children.
  • Previous reports link hepatoblastoma to trisomy 18, but cases involving mosaic trisomy 18 are scarce.

Observation:

  • An 18-month-old child presented with hemihypertrophy and developmental delay.
  • Surveillance ultrasound revealed hepatoblastoma.
  • Diagnosis of mosaic trisomy 18 was confirmed through array comparative genomic hybridization and tumor specimen analysis.

Findings:

  • This is the first reported case of hepatoblastoma in a patient with mosaic trisomy 18 and hemihypertrophy.
  • Review of existing literature indicates that trisomy 18 patients without significant comorbidities tolerate intensive hepatoblastoma treatment effectively.
  • Mosaic trisomy 18, characterized by the presence of both normal and extra chromosome 18 cells, presents unique clinical considerations.

Implications:

  • This case expands the known spectrum of clinical manifestations in mosaic trisomy 18.
  • Highlights the importance of surveillance for hepatoblastoma in children with trisomy 18, including mosaic forms.
  • Suggests potential for successful treatment outcomes in this patient population with careful management of comorbidities.